Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market – Industry Trends and Forecast to 2029

PUNE, MAHARASHTRA, INDIA, October 7, 2022 /EINPresswire.com/ -- Data Bridge Market Research has recently published a Report, titled, "Micro Invasive Glaucoma Surgery (MIGS) Devices Market" The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape.The large scale Micro Invasive Glaucoma Surgery (MIGS) Devices Market analysis report comprises of data that can be quite essential when it comes to dominate the market or making a mark in the market as a new emergent. The market research analysis has been drawn in this market report with the consistent knowledge of what the market expects, what is already available, the competitive environment, and what can be done to outshine the competition. The first class Micro Invasive Glaucoma Surgery (MIGS) Devices Market research document is a resource which provides current as well as upcoming technical and financial details of the industry to 2029.

DBMR team have a skill to serve clients on every strategic aspect including product development, application modelling, exploring niche growth opportunities and new markets. The objective of an international Micro Invasive Glaucoma Surgery (MIGS) Devices Market report is to provide a detailed analysis of the HEALTHCARE industry and its impact based on applications and on different geographical regions, strategically analyse the growth trends, and future prospects. This market analysis gives an examination of various segments that are relied upon to witness the quickest development amid the estimated forecast frame. An all inclusive Micro Invasive Glaucoma Surgery (MIGS) Devices Market business report helps to recognize the most recent improvements, share, and systems utilized by the significant market.

Data Bridge Market Research analyses that the micro invasive glaucoma surgery (MIGS) devices  market which was USD 365.07 million in 2021, would rocket up to USD 1815.29 million by 2029, and is expected to undergo a CAGR of 22.20% during the forecast period 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get a Free Sample PDF of the report – https://www.databridgemarketresearch.com/request-a-sample/?dbmr=Global-Micro-Invasive-Glaucoma-Surgery-MIGS-Devices-Market

Micro Invasive Glaucoma Surgery (MIGS) Devices Market Size

In recent years, minimally invasive glaucoma surgery (MIGS) has emerged as a viable treatment option for glaucoma. The only established treatment for glaucoma progression is to reduce intraocular pressure (IOP). Nonsurgical (topical medicines or laser therapy) and surgical methods have typically been used to accomplish this (trabeculectomy or glaucoma drainage devices).

Market Definition

The acronym micro invasive glaucoma surgery (MIGS) refers to micro invasive glaucoma surgery, a procedure used to treat glaucoma. It’s a game-changing advancement in the treatment of mild to moderate glaucoma. It is an alternative to the pharmaceuticals previously prescribed, and it also avoids the risks associated with traditional surgery. These techniques are intended to reduce the eye’s intraocular pressure in order to prevent optic nerve damage. When compared to traditional surgery, these techniques are far safer and have a much shorter recovery time.

Micro Invasive Glaucoma Surgery (MIGS) Devices Market Dynamics

Drivers

Increase in the geriatric population

The quick transition from glaucoma medicine to minimally invasive glaucoma procedures and the development of technologically improved products have increased demand for micro invasive glaucoma surgery (MIGS) devices compared to the previous year. Furthermore, demand for micro invasive glaucoma surgery (MIGS) devices has surged as a result of government measures to raise awareness about blindness prevention.

Increase in the occurrence of ophthalmic disorders

The global micro invasive glaucoma surgery (MIGS) equipment market is being driven by factors such as the growing geriatric population and the resulting blindness. The two most common age-related eye diseases, cataract and glaucoma, are the leading causes of blindness among the elderly. Furthermore, rising demand for combined glaucoma and cataract treatment due to technological advancements in devices and expanding patient awareness of minimally invasive operations are driving the growth of the micro invasive glaucoma surgery (MIGS) devices market.

Rising incidence of glaucoma across the world

Furthermore, the key companies in the ophthalmic treatment market are concentrating their efforts on developing a micro invasive glaucoma surgery (MIGS) devices stent for more successful therapy. As a result, demand for microinvasive glaucoma surgery (MIGS) devices is projected to rise.

Opportunities

The market is expected to rise due to an increase in the global elderly population, as well as an increase in the prevalence of glaucoma, a surge in demand for combined glaucoma and cataract procedures, and a shift in leading firms’ attention to the development of micro invasive glaucoma surgery (MIGS) devices   stents. In addition, AbbVie purchased Allergan plc in 2019 for eye care products such as xen, durysta, ozurdex, and refresh/optive. With these significant improvements, regional players are aiming a foothold in the minimal invasive glaucoma surgery device market. When a result, as more micro invasive glaucoma surgery (MIGS) devices are adopted, the market grows.

Restraints/Challenges

The high cost of surgical operations is due to strict rules for micro invasive glaucoma surgery (MIGS) instruments. However, inadequate reimbursement and a scarcity of qualified and skilled practitioners are two issues that could stymie the global micro invasive glaucoma surgery (MIGS) devices market’s growth.

This  micro invasive glaucoma surgery (MIGS) devices  market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the micro invasive glaucoma surgery (MIGS) devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

To Gain More Insights into the Market Analysis, Browse Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-micro-invasive-glaucoma-surgery-migs-devices-market

COVID-19 Impact on Micro Invasive Glaucoma Surgery (MIGS) Devices Market

The COVID-19 pandemic is a global public health crisis that is expected to negatively influence the market for minimally invasive glaucoma surgery (MIGS) equipment. For glaucoma surgery, glaucoma specialists favour the trabeculectomy operation. The iStent inject, followed by XEN and Preserflo, was the most regularly performed micro invasive glaucoma surgery (MIGS) device operation prior to the COVID-19 pandemic in minimally invasive glaucoma surgery (MIGS). Although trabeculectomy is still the most common established glaucoma surgery, it is being performed with less frequency during the COVID-19 pandemic because of the reduced number of postoperative visits and treatments.

Recent Development

In April, 2020 Allergan plc announced the NMPA approval of Allergan’s XEN Gel Stent for the patients suffering from refractory glaucoma. As this is the first product to get the approval in china, it will lead to increased revenue generation.

Global Micro Invasive Glaucoma Surgery (MIGS) Devices Market Scope

The micro invasive glaucoma surgery (MIGS) devices market is segmented on the basis of target, product and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Target

Trabecular Meshwork

Suprachoroidal Space

Others

Product

MIGS Stents

MIGS Shunts

OTHER (TRABECTOME/MICRO-IMPLANTS/MICRO-CATHETERS)

End-User

Eye Hospitals

Ophthalmology Clinics

Outpatient Surgical Centers

Some of the major players operating in the micro invasive glaucoma surgery (MIGS) devices market are:

Glaukos Corporation (U.S)

Ivantis Inc. (U.S)

Allergan (Ireland)

Ellex (U.S)

Alcon (Switzerland), BVI (U.S)

Johnson and Johnson Surgical Vision Care Inc. (U.S)

Microsurgical technology (U.S)

Molteno Ophthalmic Ltd. (New Zealand)

New world Medical Inc. (U.S)

Santen Pharmaceutical Co., Ltd. (Japan)

Sight Scientific (U.S)

Bausch & Lomb Incorporated. (Canada)

NeoMedix Healthcare India Pvt. Ltd. (U.S)

IOPtima (Israel)

Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=Global-Micro-Invasive-Glaucoma-Surgery-MIGS-Devices-Market

Micro Invasive Glaucoma Surgery (MIGS) Devices Market Regional Analysis/Insights

The micro invasive glaucoma surgery (MIGS) devices market is analysed and market size insights and trends are provided by country, target, product and end-user as referenced above.

The countries covered in the  micro invasive glaucoma surgery (MIGS) devices  market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is dominating the market because of the high adoption of micro invasive glaucoma surgery (MIGS) devices for the treatment of glaucoma in the region and North America as a result of an increase in research and development as well as clinical studies in the region Because of the increasing high adoption of micro invasive glaucoma surgery micro invasive glaucoma surgery (MIGS) devices for lowering IOP in difficult-to-treat patients, the United States is dominating the market and driving the growth in North America.

China is dominating Asia-Pacific market due to increasing incidence of glaucoma across and increasing government initiatives to increase awareness about inhibition of blindness and also growing awareness regarding treatment of glaucoma with micro invasive surgical procedures.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter’s five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The micro invasive glaucoma surgery (MIGS) devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for micro invasive glaucoma surgery (MIGS) devices  market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the  micro invasive glaucoma surgery (MIGS) devices  market. The data is available for historic period 2010-2020.

List of figures:

FIGURE 1 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION

FIGURE 2 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DATA TRIANGULATION

FIGURE 3 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DROC ANALYSIS

FIGURE 4 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS

FIGURE 5 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: DBMR MARKET POSITION GRID

FIGURE 8 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: MARKET END USER GRID

FIGURE 9 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: SEGMENTATION

FIGURE 11 INCREASING GERIATRIC POPULATIONAND RISING PREVALENCE OF GLAUCOMA IS EXPECTED TO DRIVE THE GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 PRODUCT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLAUCOMA SURGERY (MIGS) DEVICES MARKET

FIGURE 14 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, 2021

FIGURE 15 GLOBAL MICRO INVASIVE GLAUCOMA SURGERY (MIGS) DEVICES MARKET: BY PRODUCT, 2022-2029 (USD MILLION)

Continued...

Explore DBMR Comprehensive Coverage in Healthcare Domain:

https://www.databridgemarketresearch.com/reports/asia-pacific-micro-invasive-glaucoma-surgery-migs-devices-market

https://www.databridgemarketresearch.com/reports/north-america-micro-invasive-glaucoma-surgery-migs-devices-market

https://www.databridgemarketresearch.com/reports/middle-east-and-africa-micro-invasive-glaucoma-surgery-migs-devices-market

https://www.einpresswire.com/article/576069034/north-america-prophylaxis-of-organ-rejection-market-is-expected-to-reach-usd-1-560-26-million-by-cause-treatment-type

https://www.databridgemarketresearch.com/reports/global-craniofacial-fibrous-dysplasia-treatment-market

https://www.databridgemarketresearch.com/reports/global-optic-nerve-atrophy-treatment-market

https://www.databridgemarketresearch.com/reports/global-radio-frequency-identification-rfid-smart-cabinets-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Sopan Gedam
Data Bridge Market Research
+1 888-387-2818
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.